Research Output per year
Fingerprint Dive into the research topics where Clemens von Birgelen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
Gimbel, M., Qaderdan, K., Willemsen, L., Hermanides, R., Bergmeijer, T., de Vrey, E., Heestermans, T., Tjon Joe Gin, M., Waalewijn, R., Hofma, S., den Hartog, F., Jukema, W., von Birgelen, C., Voskuil, M., Kelder, J., Deneer, V. & ten Berg, J., 25 Apr 2020, In : The Lancet. 395, 10233, p. 1374-1381 8 p.Research output: Contribution to journal › Article › Academic › peer-review
3
Citations
(Scopus)
Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II–III and BIOFLOW II trials
1 Feb 2020, In : International journal of cardiology. 300, p. 60-65 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial
Buiten, R. A., Warta, S., Ploumen, E. H., Doggen, C., van der Heijden, L. C., Hartmann, M., Danse, P. W., Schotborgh, C. E., Scholte, M., Linssen, G. C. M., Zocca, P. & von Birgelen, C., 22 Apr 2020, In : Coronary Artery Disease.Research output: Contribution to journal › Article › Academic › peer-review
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation
Guedeney, P., Claessen, B. E., Mehran, R., Mintz, G. S., Liu, M., Sorrentino, S., Giustino, G., Farhan, S., Leon, M. B., Serruys, P. W., Smits, P. C., von Birgelen, C., Ali, Z. A., Généreux, P., Redfors, B., Madhavan, M. V., Ben-Yehuda, O. & Stone, G. W., 22 Jun 2020, In : JACC: Cardiovascular Interventions. 13, 12, p. 1417-1428 12 p.Research output: Contribution to journal › Article › Academic › peer-review
1
Citation
(Scopus)
Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
van Til, J., Oudshoorn-Groothuis, C., Weernink, M. & von Birgelen, C., 24 Apr 2020, In : Patient.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
File
Prizes
Annual Award of the Scientific Medical Journal EuroIntervention 2009
Clemens von Birgelen (Recipient), 2009
Prize: Honorary award
Second best oral abstract of the EuroPCR Congress 2010
M.Z. Basalus (Recipient), K. Tandjung (Recipient), K.G. van Houwelingen (Recipient), Aart A. van Apeldoorn (Recipient), Martinus J.K. Ankone (Recipient), F.H. de Man (Recipient) & Clemens von Birgelen (Recipient), 25 May 2010
Prize: Honorary award
Activities
Three-year clinical outcome following treatment with thin, very thin or ultrathin strut DES in small coronary vessels in BIO-RESORT
Clemens von Birgelen (Speaker)21 May 2019
Activity: Talk or presentation › Oral presentation
Supervisor of defended PhD thesis: Dual anti-platelet therapy after stenting in all-comers, ACS patients and in high-bleeding risk
Clemens von Birgelen (Examiner)13 Dec 2019
Activity: Examination
3-years BIO-RESORT: Results of the 3-arm Randomized Study in Allcomers, Treated with Contemporary Biodegradable or Durable Polymer-coated Drug-eluting Stents
Clemens von Birgelen (Speaker)5 Mar 2019
Activity: Talk or presentation › Oral presentation
BIO-RESORT Silent Diabetes Substudy: Impact of ‘Silent‘ Diabetes on Clinical Outcome
Clemens von Birgelen (Speaker), Marlies Melanie Kok (Contributor)18 May 2018
Activity: Talk or presentation › Oral presentation
BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients with Coronary Artery Disease
Clemens von Birgelen (Speaker)30 Oct 2018
Activity: Talk or presentation › Oral presentation